RE: Forward Planning16 Aug 2021 08:56
I have never considered a potential takeover scenario, however at these levels presents excellent value and I can see the market picking up on this.
Do expect a timeline on the PK soon, as they were aware of this a few months ago and an update on Ureka and performance from the operatives in our french labs with the development of our peptide offering.
Should be a news rich period.